Sarepta Therapeutics (SRPT) Consolidated Net Income: 2012-2025
Historic Consolidated Net Income for Sarepta Therapeutics (SRPT) over the last 12 years, with Jun 2025 value amounting to -$447.6 million.
- Sarepta Therapeutics' Consolidated Net Income fell 7028.08% to -$447.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$248.7 million, marking a year-over-year decrease of 627.64%. This contributed to the annual value of $235.0 million for FY2024, which is 143.83% up from last year.
- Sarepta Therapeutics' Consolidated Net Income amounted to -$447.6 million in Q2 2025, which was down 381.84% from $158.8 million recorded in Q4 2024.
- Over the past 5 years, Sarepta Therapeutics' Consolidated Net Income peaked at $158.8 million during Q4 2024, and registered a low of -$516.8 million during Q1 2023.
- In the last 3 years, Sarepta Therapeutics' Consolidated Net Income had a median value of $6.5 million in 2024 and averaged -$83.2 million.
- Per our database at Business Quant, Sarepta Therapeutics' Consolidated Net Income skyrocketed by 248.80% in 2024 and then crashed by 7,028.08% in 2025.
- Over the past 5 years, Sarepta Therapeutics' Consolidated Net Income (Quarterly) stood at -$122.0 million in 2021, then increased by 9.94% to -$109.9 million in 2022, then surged by 141.44% to $45.5 million in 2023, then spiked by 248.80% to $158.8 million in 2024, then crashed by 7,028.08% to -$447.6 million in 2025.
- Its last three reported values are -$447.6 million in Q2 2025, $158.8 million for Q4 2024, and $33.6 million during Q3 2024.